Cytotoxic Effects of Fucoidan Nanoparticles against Osteosarcoma

In this study, we analyzed the size-dependent bioactivities of fucoidan by comparing the cytotoxic effects of native fucoidan and fucoidan lipid nanoparticles on osteosarcoma in vitro and in vivo. In vitro experiments indicated that nanoparticle fucoidan induced apoptosis of an osteosarcoma cell line more efficiently than native fucoidan. The more potent effects of nanoparticle fucoidan, relative to native fucoidan, were confirmed in vivo using a xenograft osteosarcoma model. Caco-2 cell transport studies showed that permeation of nanoparticle fucoidan was higher than native fucoidan. The higher bioactivity and superior bioavailability of nanoparticle fucoidan could potentially be utilized to develop novel therapies for osteosarcoma.     

Induction of Apoptosis by Fucoidan in Human Leukemia U937 Cells through Activation of p38 MAPK and Modulation of Bcl-2 Family

The present study investigated possible mechanisms on the apoptosis induction of human leukemic cells by fucoidan, a sulfated polysaccharide found in marine algae. Fucoidan treatment of cells resulted in inhibition of growth and induction of apoptosis, as measured by 3-(4,5-dimetylthiazol-2-yl)-2,5-diphenyl-tetrazolium (MTT) assay, fluorescence microscopy, DNA fragmentation, and flow cytometry analysis. The increase in apoptosis was associated with the proteolytic activation of caspases, Bid cleavage, insertion of pro-apoptotic Bax into the mitochondria, release of cytochrome c from mitochondria to cytosol, and loss of mitochondria membrane potential (MMP) in U937 cells. However, apoptosis induced by fucoidan was attenuated by caspase inhibitors, indicating that fucoidan-induced apoptosis was dependent on the activation of caspases. Furthermore, fucoidan treatment effectively activated the p38 mitogen-activated protein kinase (MAPK) and p38 MAPK inhibitor, SB203580, and significantly reduced fucoidan-induced apoptosis through inhibition of Bax translocation and caspases activation, suggesting that the activation of p38 MAPK may play a key role in fucoidan-induced apoptosis. In addition, the authors found fucoidan-induced significantly attenuated in Bcl-2 overexpressing U937 cells, and pretreatment with fucoidan and HA 14-1, a small-molecule Bcl-2 inhibitor, markedly increased fucoidan-mediated apoptosis in Bcl-2 overexpressing U937 cells. Our findings imply that we may attribute some of the biological functions of p38 MAPK and Bcl-2 to their ability to inhibit fucoidan-induced apoptosis.     

褐藻糖胶对黄颡鱼幼鱼中脂肪酸的影响

为研究褐藻糖胶作为饲料添加剂对黄颡鱼幼鱼脂肪酸的影响,选取大小、体重相近的黄颡鱼幼鱼,随机分为对照组和试验组,对照组饲喂不添加褐藻糖胶的基础饲料,试验组饲喂添加0.1%褐藻糖胶的饲料,采用气相色谱质谱联用技术(GC-MS)分析不同喂养时间(1、2、4、8周)下试验组和对照组黄颡鱼幼鱼脂肪酸含量的变化。结果表明,黄颡鱼幼鱼体内共检测出15个总脂肪酸(TFA)和17个游离脂肪酸(FFA)。方差分析结果表明,黄颡鱼幼鱼TFA中C18:1 (n-9)、C20:4(n-5)和C22:6 (n-3)具有交互作用,而大部分FFA间都存在交互作用。喂养时间对黄颡鱼幼鱼脂肪酸有显著影响(P<0.05),随着喂养时间的延长,游离的单不饱和脂肪酸(MUFA)含量呈先减少后增加趋势,而总MUFA含量呈先增加后减少趋势;黄颡鱼幼鱼游离脂肪酸和总脂肪酸中饱和脂肪酸(SFA)均呈先增加后减少趋势,而多不饱和脂肪酸(PUFA)呈先下降后升高趋势。0.1%褐藻糖胶对黄颡鱼幼鱼TFA中C18:1 (n-9)、C20:4(n-5)和C22:6 (n-3)含量影响显著(P<0.05),对FFA组分含量的影响均显著(P<0.05),试验组黄颡鱼幼鱼SFA含量高于对照组,MUFA含量低于对照组,PUFA在喂养第2周时高于对照组,喂养第8周时低于对照组。此外,黄颡鱼幼鱼C20:3(n-3)/C22:6(n-3)的比值小于0.4,且喂养0.1%褐藻糖胶第8周时,黄颡鱼幼鱼C22:6(n-3)和C20:4(n-5)含量明显高于对照组,说明褐藻糖胶有益于黄颡鱼产卵和孵化,有助于黄颡鱼幼鱼的发育生长。本研究结果为黄颡鱼的健康养殖提供了基础数据。     

树皮藻岩藻聚糖硫酸酯的纯化及其化学结构研究

为研究树皮藻Ecklonia maxima岩藻聚糖硫酸酯的单糖组成及其化学结构,以产自南非的树皮藻为原料测定其基本成分,采用DEAE-Sepharose Fast Flow阴离子层析柱对树皮藻岩藻聚糖硫酸酯粗品进行分离纯化,通过柱前衍生高效液相色谱法、红外光谱法和核磁共振波谱法测定单糖组成和化学结构。结果表明:树皮藻干基中基本营养成分分别为灰分18.59%、蛋白质9.16%、脂肪0.74%;对树皮藻岩藻聚糖硫酸酯粗品进行纯化得到4个组分,分别命名为SPF1、SPF2、SPF3、SPF4,收集冻干各组分,检测各组分得率分别为18.19%、24.02%、5.61%、4.23%,硫酸根含量分别为12.07%、5.44%、15.58%、19.30%;4个组分主要由岩藻糖、半乳糖、鼠李糖、甘露糖和葡萄糖醛酸组成,还含有少量的葡萄糖和木糖,其中SPF3、SPF4主要由岩藻糖和半乳糖组成,岩藻糖含量分别为70.92%和86.20%,4个组分的红外光谱显示出典型的多糖吸收峰,SPF1、SPF2在13C核磁共振谱177×10-6附近均出现糖醛酸C6信号峰,SPF3、SPF4在18×10-6附近均出现信号峰,为α-L-吡喃岩藻糖C6信号峰。     

Anti-Inflammatory Effects of Sulfated Polysaccharide from Sargassum swartzii in Macrophages via Blocking TLR/NF-Κb Signal Transduction

This study involves enzymatic extraction of fucoidan from Sargassum swartzii and further purification via ion-exchange chromatography. The chemical and molecular characteristics of isolated fucoidan is evaluated concerning its anti-inflammatory potential in RAW 264.7 macrophages under LPS induced conditions. Structural properties of fucoidan were assessed via FTIR and NMR spectroscopy. NO production stimulated by LPS was significantly declined by fucoidan. This was witnessed to be achieved via fucoidan acting on mediators such as iNOS and COX-2 including pro-inflammatory cytokines (TNF-α, IL-6, and IL-1β), with dose dependent down-regulation. Further, the effect is exhibited by the suppression of TLR mediated MyD88, IKK complex, ultimately hindering NF-κB and MAPK activation, proposing its therapeutic applications in inflammation related disorders. The research findings provide an insight in relation to the sustainable utilization of fucoidan from marine brown algae S. swartzii as a potent anti-inflammatory agent in the nutritional, pharmaceutical, and cosmeceutical sectors.     

Evaluation of a Brown Seaweed Extract from Dictyosiphon foeniculaceus as a Potential Therapeutic Agent for the Treatment of Glioblastoma and Uveal Melanoma

Ingredients of brown seaweed like fucoidans are often described for their beneficial biological effects, that might be interesting for a medical application. In this study, we tested an extract from Dictyosiphon foeniculaceus (DF) to evaluate the effects in glioblastoma and uveal melanoma, looking for a possible anti-cancer treatment. We investigated toxicity, VEGF (vascular endothelial growth factor) secretion and gene expression of tumor and non-tumor cells. SVGA (human fetal astrocytes), the human RPE (retinal pigment epithelium) cell line ARPE-19, the tumor cell line OMM-1 (human uveal melanoma), and two different human primary glioblastoma cultures (116-14 and 118-14) were used. Tests for cell viability were conducted with MTS-Assay (3-(4,5-Dimethylthiazol-2-yl)-5-(3-carboxymethoxyphenyl)-2-(4-sulfophenyl)-2H-tetrazolium), and the proliferation rate was determined with cell counting. VEGF secretion was assessed with ELISA (enzyme-linked immunosorbent assay). The gene expression of VEGF receptor 1 (VEGFR1), VEGF receptor 2 (VEGFR2) and VEGF-A was determined with real-time qPCR (quantitative polymerase chain reaction). DF lowered the cell viability of OMM-1. Proliferation rates of ARPE-19 and OMM-1 were decreased. The VEGF secretion was inhibited in ARPE-19 and OMM-1, whereas it was increased in SVGA and 116-14. The expression of VEGFR1 was absent and not influenced in OMM-1 and ARPE-19. VEGFR2 expression was lowered in 116-14 after 24 h, whereas VEGF-A was increased in 118-14 after 72 h. The extract lowered cell viability slightly and was anti-proliferative depending on the cell type investigated. VEGF was heterogeneously affected. The results in glioblastoma were not promising, but the anti-tumor properties in OMM-1 could make them interesting for further research concerning cancer diseases in the human eye.     

海带岩藻聚糖硫酸酯酶解工艺及分离和纯化研究

岩藻聚糖硫酸酯是一种具有多种生物活性的多糖,对用纤维素酶、果胶酶酶解制备海带岩藻聚糖硫酸酯的工艺进行了研究,正交试验结果表明:纤维素酶、果胶酶优化的酶解工艺参数为:纤维素酶0.221%、果胶酶0.074%,温度50℃,pH值4.5,时间50min。经DEAE-52纤维素离子交换柱层析分离得到3个岩藻聚糖硫酸酯组分,3个组分经Sephadex G-200凝胶柱层析进一步纯化得5个分子量很大(大于2MDa)的组分,可能为岩藻聚糖硫酸酯的凝聚体,另5个组分的分子量为57.8KDa、115KDa、125KDa、154KDa、206KDa。     

Fucoidans as Potential Inhibitors of HIV-1

The antiviral activity of different structure fucoidans (α-l-fucans and galactofucans) was studied using two model viral systems based on a lentiviral vectors and a replication competent Moloney murine leukemia virus (Mo-MuLV). It was found that investigated fucoidans have no cytotoxic effects on Jurkat and SC-1cell at the concentration range of 0.001–100 µg/mL. Fucoidans with different efficiency suppressed transduction of Jurkat cell line by pseudo-HIV-1 particles carrying the envelope protein of HIV-1 and infection of SC-1 cells by Mo-MuLV. According to our data, all natural fucoidans can be considered as potential anti-HIV agents regardless of their carbohydrate backbone and degree of sulfating, since their activity is shown at low concentrations (0.001–0.05 µg/mL). High molecular weight fucoidans isolated from Saccharina cichorioides (1.3-α-l-fucan), and S. japonica (galactofucan) were the most effective inhibitors.     

Purification of a Low Molecular Weight Fucoidan for SPECT Molecular Imaging of Myocardial Infarction

Fucoidans constitute a large family of sulfated polysaccharides with several biochemical properties. A commercial fucoidan from brown algae, containing low molecular weight polysaccharidic species constituted of l-fucose, uronic acids and sulfate groups, was simply treated here with calcium acetate solution. This treatment led to a purified fraction with a yield of 45%. The physicochemical characterizations of the purified fucoidan using colorimetric assay, MALLS, dRI, FT-IR, NMR, exhibited molecular weight distributions and chemical profiles similar for both fucoidans whereas the sulfate and l-fucose contents increased by 16% and 71%, respectively. The biodistribution study in rat of both compounds labeled with ^99mTc evidenced a predominant renal elimination of the purified fucoidan, but the crude fucoidan was mainly retained in liver and spleen. In rat myocardial ischemia-reperfusion, we then demonstrated the better efficiency of the purified fucoidan. This purified sulfated polysaccharide appears promising for the development of molecular imaging in acute coronary syndrome.